Latest News about BMY
Recent news which mentions BMY
Options Corner: Political Turmoil Sets Up A Contrarian Call Spread For Bristol-Myers Squibb
May 16, 2025
Tickers
BMY
From Benzinga
From Benzinga
Tickers
BMY
From Motley Fool
From Benzinga
From Benzinga
From Benzinga
EXCLUSIVE: FDA Clears Lantern Pharma's Planned Phase 1b/2 Trial of LP-184 In Treatment-Resistant Lung Cancer Patients
May 12, 2025
From Benzinga
Cathie Wood Says AI Innovation In Healthcare Will Be More 'Profound' Than Autonomous Taxi Networks, Humanoid Robots
May 12, 2025
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
May 06, 2025
From Benzinga
FDA Pushes Potential Approval For Cytokinetics' Experimental Heart Drug By Three Months
May 02, 2025
From Benzinga
From Motley Fool
Top 3 Health Care Stocks That May Rocket Higher In April
April 28, 2025
From Benzinga
From Motley Fool
From Benzinga
Gold Gains 1%; Bristol Myers Squibb Posts Upbeat Results
April 24, 2025
From Benzinga
From Benzinga
From Benzinga
US Stock Futures Drop Amid Mixed Signals From White House On US-China Trade: 'Focus On Quality In A Diversified Manner,' Says Expert
April 24, 2025
From Benzinga
Earnings Scheduled For April 24, 2025
April 24, 2025
From Benzinga
From Benzinga
Dow Jumps Over 400 Points Amid China Tariff Hopes, Investor Fear Eases: Greed Index Remains In 'Fear' Zone
April 24, 2025
From Benzinga
From Benzinga
Bristol Myers' Cobenfy Falls Short On Primary Endpoint In Phase 3 Schizophrenia Trial, Stock Slides
April 23, 2025
From Benzinga
Bristol Myers Analyst Says FDA Update Is A Win For Camzyos With Simpler Use, Broader Reach
April 21, 2025
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.